-
公开(公告)号:US20100152193A1
公开(公告)日:2010-06-17
申请号:US12626982
申请日:2009-11-30
申请人: Daniela Alberati , Luca Gobbi , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rosa Maria Rodriguez-Sarmiento , Mark Rogers-Evans , Markus Rudolph
发明人: Daniela Alberati , Luca Gobbi , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rosa Maria Rodriguez-Sarmiento , Mark Rogers-Evans , Markus Rudolph
IPC分类号: A61K31/501 , C07D403/04 , A61P25/18
CPC分类号: C07D403/04 , C07D403/14 , C07D405/14
摘要: The present invention is concerned with novel pyridazinones of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of CNS disorders.
摘要翻译: 本发明涉及式(I)的新的哒嗪酮,其中R1,R2,R3和R4如说明书和权利要求书中所定义,以及其生理上可接受的盐和酯。 这些化合物抑制PDE10A,可用于治疗CNS疾病。
-
公开(公告)号:US08178538B2
公开(公告)日:2012-05-15
申请号:US12626982
申请日:2009-11-30
申请人: Daniela Alberati , Luca Gobbi , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rosa Maria Rodriguez-Sarmiento , Mark Rogers-Evans , Markus Rudolph
发明人: Daniela Alberati , Luca Gobbi , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rosa Maria Rodriguez-Sarmiento , Mark Rogers-Evans , Markus Rudolph
IPC分类号: A61K31/501 , C07D403/04
CPC分类号: C07D403/04 , C07D403/14 , C07D405/14
摘要: The present invention is concerned with novel pyridazinones of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of CNS disorders.
摘要翻译: 本发明涉及式(I)的新的哒嗪酮,其中R 1,R 2,R 3和R 4如说明书和权利要求书中所定义,以及其生理上可接受的盐和酯。 这些化合物抑制PDE10A,可用于治疗CNS疾病。
-
公开(公告)号:US09187455B2
公开(公告)日:2015-11-17
申请号:US12705988
申请日:2010-02-16
申请人: Daniela Alberati , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rosa Maria Rodriguez Sarmiento , Mark Rogers-Evans , Markus Rudolph
发明人: Daniela Alberati , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rosa Maria Rodriguez Sarmiento , Mark Rogers-Evans , Markus Rudolph
IPC分类号: A61K31/501 , C07D237/04 , C07D403/14
CPC分类号: C07D403/14
摘要: The present invention is concerned with novel pyridazinone derivatives of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.
摘要翻译: 本发明涉及式(I)的新的哒嗪酮衍生物,其中R 1,R 2,R 3和R 4如说明书和权利要求书中所定义,以及其生理上可接受的盐和酯。 这些化合物抑制PDE10A,可用作药物。
-
公开(公告)号:US20100216793A1
公开(公告)日:2010-08-26
申请号:US12705988
申请日:2010-02-16
申请人: Daniela Alberati , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rose Maria Rodriguez Sarmiento , Mark Rogers-Evans , Markus Rudolph
发明人: Daniela Alberati , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rose Maria Rodriguez Sarmiento , Mark Rogers-Evans , Markus Rudolph
IPC分类号: A61K31/501 , C07D401/14 , C07D405/14 , C07D413/14 , A61K31/5377
CPC分类号: C07D403/14
摘要: The present invention is concerned with novel pyridazinone derivatives of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.
摘要翻译: 本发明涉及式(I)的新的哒嗪酮衍生物,其中R 1,R 2,R 3和R 4如说明书和权利要求书中所定义,以及其生理上可接受的盐和酯。 这些化合物抑制PDE10A,可用作药物。
-
公开(公告)号:US20110071128A1
公开(公告)日:2011-03-24
申请号:US12886657
申请日:2010-09-21
申请人: Daniela Alberati , Rubén Alvarez Sánchez , Konrad Bleicher , Alexander Flohr , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
发明人: Daniela Alberati , Rubén Alvarez Sánchez , Konrad Bleicher , Alexander Flohr , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
IPC分类号: A61K31/553 , C07D471/04 , C07D487/04 , C07D491/107 , A61K31/437 , A61K31/5377 , A61K31/5025 , A61K31/496 , A61P25/18
CPC分类号: C07D471/04 , A61K31/437 , A61K31/496 , A61K31/5025 , A61K31/5377 , A61K31/553 , C07D487/04
摘要: The invention is concerned with novel imidazopyridine derivatives of formula (I) wherein R1, R2, R3, R4, R5 and A are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of various diseases, including central nervous system disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia.
摘要翻译: 本发明涉及式(I)的新咪唑并吡啶衍生物,其中R 1,R 2,R 3,R 4,R 5和A如说明书和权利要求书中所定义,以及其生理上可接受的盐和酯。 这些化合物抑制PDE10A,可用于治疗各种疾病,包括中枢神经系统疾病如阿尔茨海默病,帕金森病和精神分裂症。
-
公开(公告)号:US08263584B2
公开(公告)日:2012-09-11
申请号:US13151310
申请日:2011-06-02
申请人: Daniela Alberati , Ruben Alvarez Sanchez , Konrad Bleicher , Alexander Flohr , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
发明人: Daniela Alberati , Ruben Alvarez Sanchez , Konrad Bleicher , Alexander Flohr , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
IPC分类号: A61K31/437 , A61K31/5377 , A61K31/4985 , A61K31/553 , A61K31/541 , C07D519/00 , C07D471/04 , A61P25/22 , A61P25/18
CPC分类号: C07D471/04 , A61K31/437 , A61K31/496 , A61K31/5025 , A61K31/5377 , A61K31/553 , C07D487/04
摘要: The invention is concerned with novel imidazopyridine derivatives of formula (I) wherein R1, R2, R3, R4, R5 and A are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of various diseases, including central nervous system disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia.
摘要翻译: 本发明涉及式(I)的新咪唑并吡啶衍生物,其中R 1,R 2,R 3,R 4,R 5和A如说明书和权利要求书中所定义,以及其生理上可接受的盐和酯。 这些化合物抑制PDE10A,可用于治疗各种疾病,包括中枢神经系统疾病如阿尔茨海默病,帕金森病和精神分裂症。
-
公开(公告)号:US08017604B2
公开(公告)日:2011-09-13
申请号:US12886657
申请日:2010-09-21
申请人: Daniela Alberati , Rubén Alvarez Sánchez , Konrad Bleicher , Alexander Flohr , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
发明人: Daniela Alberati , Rubén Alvarez Sánchez , Konrad Bleicher , Alexander Flohr , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
IPC分类号: A61K31/535 , A61K31/44 , A01N43/42 , C07D491/02 , C07D498/02 , C07D413/00
CPC分类号: C07D471/04 , A61K31/437 , A61K31/496 , A61K31/5025 , A61K31/5377 , A61K31/553 , C07D487/04
摘要: The invention is concerned with novel imidazopyridine derivatives of formula (I) wherein R1, R2, R3, R4, R5 and A are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of various diseases, including central nervous system disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia.
摘要翻译: 本发明涉及式(I)的新咪唑并吡啶衍生物,其中R 1,R 2,R 3,R 4,R 5和A如说明书和权利要求书中所定义,以及其生理上可接受的盐和酯。 这些化合物抑制PDE10A,可用于治疗各种疾病,包括中枢神经系统疾病如阿尔茨海默病,帕金森病和精神分裂症。
-
公开(公告)号:US08410117B2
公开(公告)日:2013-04-02
申请号:US13049941
申请日:2011-03-17
申请人: Ruben Alvarez Sanchez , Konrad Bleicher , Alexander Flohr , Luca Gobbi , Katrin Groebke Zbinzen , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
发明人: Ruben Alvarez Sanchez , Konrad Bleicher , Alexander Flohr , Luca Gobbi , Katrin Groebke Zbinzen , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
IPC分类号: A01N43/90 , A61K31/519 , C07D487/00
CPC分类号: C07D487/04 , C07D519/00
摘要: The invention is concerned with novel imidazopyrimidine derivatives of formula (I) wherein R1, R2 and R8 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.
摘要翻译: 本发明涉及式(I)的新型咪唑并嘧啶衍生物,其中R 1,R 2和R 8如说明书和权利要求书中所定义,以及其生理上可接受的盐和酯。 这些化合物抑制PDE10A,可用作药物。
-
公开(公告)号:US20110237564A1
公开(公告)日:2011-09-29
申请号:US13049941
申请日:2011-03-17
申请人: Rubén Alvarez Sánchez , Konrad Bleicher , Alexander Flohr , Luca Gobbi , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
发明人: Rubén Alvarez Sánchez , Konrad Bleicher , Alexander Flohr , Luca Gobbi , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
IPC分类号: A61K31/519 , C07D487/04 , A61K31/5377 , A61K31/541 , C07D513/04 , A61P25/18
CPC分类号: C07D487/04 , C07D519/00
摘要: The invention is concerned with novel imidazopyrimidine derivatives of formula (I) wherein R1, R2 and R8 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.
摘要翻译: 本发明涉及式(I)的新型咪唑并嘧啶衍生物,其中R 1,R 2和R 8如说明书和权利要求书中所定义,以及其生理上可接受的盐和酯。 这些化合物抑制PDE10A,可用作药物。
-
公开(公告)号:US08772510B2
公开(公告)日:2014-07-08
申请号:US13598848
申请日:2012-08-30
申请人: Stephan Bachmann , Alexander Flohr , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
发明人: Stephan Bachmann , Alexander Flohr , Katrin Groebke Zbinden , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Markus Rudolph
IPC分类号: C07D249/04 , C07D233/54 , C07D231/10 , C07D207/30
CPC分类号: C07D471/04 , C07D231/14 , C07D233/90 , C07D401/14 , C07D403/12 , C07D403/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
摘要: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R5, W, X, X1, Y, Y1, Z and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used in the treatment of CNS disorders such as schizophrenia, Alzheimer's disease, and Parkinson's disease.
摘要翻译: 本发明涉及式(I)化合物,其中R 1,R 2,R 3,R 5,W,X,X 1,Y,Y 1,Z和Z 1如说明书和权利要求书中所定义,以及生理上可接受的盐 其中。 这些化合物抑制PDE10A,可用于治疗CNS疾病如精神分裂症,阿尔茨海默病和帕金森病。
-
-
-
-
-
-
-
-
-